In future work, it will be interesting to determine in HHT models whether VE-cadherin proteolytic processing accompanies vascular lesion development and is a consequence of reduced BMP9/10-ALK1-ENG signaling, as suggested by our in vitro studies. This evidence concerns the gene GDF2 and hereditary hemorrhagic telangiectasia.